Featured News

Celiac Disease Foundation quoted in Healthline article covering the Nexvax2 therapeutic vaccine candidate.

How the Gluten-Free Craze Affects Celiac Patients

Celiac Disease Foundation Attends PCORI 2018 Annual Meeting and Advocacy Day

In a Medscape Gastroenterology article covering Digestive Disease Week (DDW) 2018, William Balistreri, MD, reported on the studies presented that addressed reliable, cost-effective celiac disease detection. One of the studies…

Previous studies have found celiac disease to be associated with several neurological complications. In a new study, researchers reviewed the available literature to determine the prevalence of epilepsy in patients…

At the 2018 ACG Annual Scientific Meeting, Columbia University Medical Center researchers – including Celiac Disease Foundation Medical Advisory Board member Peter Green and Research Committee member Benjamin Lebwohl –…

ImmusanT, Inc., announces first patient dosed in Phase 2 clinical trial, RESET CeD, testing the safety and efficacy of Nexvax2®, a therapeutic vaccine for the treatment of celiac disease patients.

Previous studies have found celiac disease to be associated with several conditions affecting pregnancy and female reproductive outcomes. In a new population-based study, researchers sought to determine how celiac disease…

In a new study, researchers conducted a meta-analysis and review of studies from all over the world to estimate the global prevalence of celiac disease and identify possible variations in…

On June 20, 2018, the Medical Board of the National Psoriasis Foundation published new dietary recommendations for adults with psoriasis in JAMA Dermatology.